These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 27417157)

  • 1. Tumourigenicity and Immunogenicity of Induced Neural Stem Cell Grafts Versus Induced Pluripotent Stem Cell Grafts in Syngeneic Mouse Brain.
    Gao M; Yao H; Dong Q; Zhang H; Yang Z; Yang Y; Zhu J; Xu M; Xu R
    Sci Rep; 2016 Jul; 6():29955. PubMed ID: 27417157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brief Report: Immune Microenvironment Determines the Immunogenicity of Induced Pluripotent Stem Cell Derivatives.
    Todorova D; Kim J; Hamzeinejad S; He J; Xu Y
    Stem Cells; 2016 Feb; 34(2):510-5. PubMed ID: 26439188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurotrophy and immunomodulation of induced neural stem cell grafts in a mouse model of closed head injury.
    Gao M; Yao H; Dong Q; Zhang Y; Yang Y; Zhang Y; Yang Z; Xu M; Xu R
    Stem Cell Res; 2017 Aug; 23():132-142. PubMed ID: 28743043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induced pluripotent stem cell-derived gamete-associated proteins incite rejection of induced pluripotent stem cells in syngeneic mice.
    Kim EM; Manzar G; Zavazava N
    Immunology; 2017 Jun; 151(2):191-197. PubMed ID: 28185259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of immune response to differentiated cells derived from syngeneic induced pluripotent stem cells.
    Guha P; Morgan JW; Mostoslavsky G; Rodrigues NP; Boyd AS
    Cell Stem Cell; 2013 Apr; 12(4):407-12. PubMed ID: 23352605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumorigenic and Immunogenic Properties of Induced Pluripotent Stem Cells: a Promising Cancer Vaccine.
    Qiao Y; Agboola OS; Hu X; Wu Y; Lei L
    Stem Cell Rev Rep; 2020 Dec; 16(6):1049-1061. PubMed ID: 32939647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transplantation of induced neural stem cells (iNSCs) into chronically demyelinated corpus callosum ameliorates motor deficits.
    Sullivan GM; Knutsen AK; Peruzzotti-Jametti L; Korotcov A; Bosomtwi A; Dardzinski BJ; Bernstock JD; Rizzi S; Edenhofer F; Pluchino S; Armstrong RC
    Acta Neuropathol Commun; 2020 Jun; 8(1):84. PubMed ID: 32517808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathological classification of human iPSC-derived neural stem/progenitor cells towards safety assessment of transplantation therapy for CNS diseases.
    Sugai K; Fukuzawa R; Shofuda T; Fukusumi H; Kawabata S; Nishiyama Y; Higuchi Y; Kawai K; Isoda M; Kanematsu D; Hashimoto-Tamaoki T; Kohyama J; Iwanami A; Suemizu H; Ikeda E; Matsumoto M; Kanemura Y; Nakamura M; Okano H
    Mol Brain; 2016 Sep; 9(1):85. PubMed ID: 27642008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity of induced pluripotent stem cells.
    Zhao T; Zhang ZN; Rong Z; Xu Y
    Nature; 2011 May; 474(7350):212-5. PubMed ID: 21572395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation of Neural Stem Cells and Progenitors: Neuronal Production and Grafting Applications.
    Zholudeva LV; Jin Y; Qiang L; Lane MA; Fischer I
    Methods Mol Biol; 2021; 2311():73-108. PubMed ID: 34033079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of intracerebral transplantation effects of different stem cells on rodent stroke models.
    Wu Y; Wu J; Ju R; Chen Z; Xu Q
    Cell Biochem Funct; 2015 Jun; 33(4):174-82. PubMed ID: 25914321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potent tumor tropism of induced pluripotent stem cells and induced pluripotent stem cell-derived neural stem cells in the mouse intracerebral glioma model.
    Yamazoe T; Koizumi S; Yamasaki T; Amano S; Tokuyama T; Namba H
    Int J Oncol; 2015 Jan; 46(1):147-52. PubMed ID: 25310640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of multiple sclerosis by transplantation of neural stem cells derived from induced pluripotent stem cells.
    Zhang C; Cao J; Li X; Xu H; Wang W; Wang L; Zhao X; Li W; Jiao J; Hu B; Zhou Q; Zhao T
    Sci China Life Sci; 2016 Sep; 59(9):950-7. PubMed ID: 27233903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells.
    Araki R; Uda M; Hoki Y; Sunayama M; Nakamura M; Ando S; Sugiura M; Ideno H; Shimada A; Nifuji A; Abe M
    Nature; 2013 Feb; 494(7435):100-4. PubMed ID: 23302801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal differentiation of Sandhoff disease model mouse-derived multipotent stem cells toward a neural lineage.
    Ogawa Y; Kaizu K; Yanagi Y; Takada S; Sakuraba H; Oishi K
    PLoS One; 2017; 12(6):e0178978. PubMed ID: 28575132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human induced pluripotent stem cell-derived neural stem cells survive, migrate, differentiate, and improve neurologic function in a rat model of middle cerebral artery occlusion.
    Yuan T; Liao W; Feng NH; Lou YL; Niu X; Zhang AJ; Wang Y; Deng ZF
    Stem Cell Res Ther; 2013 Jun; 4(3):73. PubMed ID: 23769173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low immunogenicity of mouse induced pluripotent stem cell-derived neural stem/progenitor cells.
    Itakura G; Ozaki M; Nagoshi N; Kawabata S; Nishiyama Y; Sugai K; Iida T; Kashiwagi R; Ookubo T; Yastake K; Matsubayashi K; Kohyama J; Iwanami A; Matsumoto M; Nakamura M; Okano H
    Sci Rep; 2017 Oct; 7(1):12996. PubMed ID: 29021610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Embryonic stem cell immunogenicity increases upon differentiation after transplantation into ischemic myocardium.
    Swijnenburg RJ; Tanaka M; Vogel H; Baker J; Kofidis T; Gunawan F; Lebl DR; Caffarelli AD; de Bruin JL; Fedoseyeva EV; Robbins RC
    Circulation; 2005 Aug; 112(9 Suppl):I166-72. PubMed ID: 16159810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor tropism of intravenously injected human-induced pluripotent stem cell-derived neural stem cells and their gene therapy application in a metastatic breast cancer model.
    Yang J; Lam DH; Goh SS; Lee EX; Zhao Y; Tay FC; Chen C; Du S; Balasundaram G; Shahbazi M; Tham CK; Ng WH; Toh HC; Wang S
    Stem Cells; 2012 May; 30(5):1021-9. PubMed ID: 22311724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic Administration of Induced Neural Stem Cells Regulates Complement Activation in Mouse Closed Head Injury Models.
    Gao M; Dong Q; Yao H; Lu Y; Ji X; Zou M; Yang Z; Xu M; Xu R
    Sci Rep; 2017 Apr; 7():45989. PubMed ID: 28383046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.